{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T04:48:44Z","timestamp":1771994924771,"version":"3.50.1"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.thromres.2021.04.011","type":"journal-article","created":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T15:49:31Z","timestamp":1618847371000},"page":"18-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity"],"prefix":"10.1016","volume":"203","author":[{"given":"Ilaria","family":"Avarello","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanna","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena Loredana","family":"Zighetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena M.","family":"Faioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2021.04.011_bb0005","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev-pharmtox-010611-134633","article-title":"Old versus new oral anticoagulants: focus on pharmacology","volume":"52","author":"Fareed","year":"2012","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0010","series-title":"Evidence-based Management of Anticoagulant Therapy. Antithrombotic Therapy and Prevention of Thrombosis","first-page":"e152S","volume":"141","author":"Holbrook","year":"2012"},{"key":"10.1016\/j.thromres.2021.04.011_bb0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.15420\/ecr.2017:11:2","article-title":"Direct oral anticoagulants: a quick guide","volume":"12","author":"Sikorska","year":"2017","journal-title":"Eur. Cardiol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0020","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s11739-017-1678-9","article-title":"Vitamin K antagonist therapy: changes in the treated populations and in management results in Italian anticoagulation clinics compared with those recorded 20 years ago","volume":"12","author":"Palareti","year":"2017","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.thromres.2021.04.011_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/0897190010362177","article-title":"Patient factors that influence warfarin dose response","volume":"23","author":"White","year":"2010","journal-title":"J. Pharm. Pract."},{"key":"10.1016\/j.thromres.2021.04.011_bb0030","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/FPC.0000000000000244","article-title":"Genetic determinants of variability in warfarin response after the dose-titration phase","volume":"26","author":"Iwuchukwu","year":"2016","journal-title":"Pharmacogenet. Genomics"},{"key":"10.1016\/j.thromres.2021.04.011_bb0035","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1161\/CIRCULATIONAHA.107.750000","article-title":"Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range","volume":"118","author":"Connolly","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2021.04.011_bb0040","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V","volume":"167","author":"White","year":"2007","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.thromres.2021.04.011_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113627","article-title":"Sex differences in treatment quality of self-managed oral anticoagulant therapy: 6,900 patient-years of follow-up","volume":"9","author":"Nilsson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2021.04.011_bb0050","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/phar.2324","article-title":"Predictors of warfarin time in therapeutic range after continuous-flow left ventricular assist device","volume":"39","author":"Henderson","year":"2019","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2021.04.011_bb0055","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/j.1538-7836.2010.03996.x","article-title":"Patient characteristics associated with oral anticoagulation control: results of the Veterans AffaiRs Study to Improve Anticoagulation (VARIA)","volume":"8","author":"Rose","year":"2010","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.04.011_bb0060","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/j.amjcard.2012.08.014","article-title":"Relation of gender-specific risk of ischemic stroke in patients with atrial fibrillation to differences in warfarin anticoagulation control (from AFFIRM)","volume":"110","author":"Sullivan","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0065","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1378\/chest.13-0054","article-title":"Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT\u2082R\u2082 score","volume":"144","author":"Apostolakis","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.thromres.2021.04.011_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ahj.2015.03.017","article-title":"Patients\u2019 time in therapeutic range on warfarin among US patients with atrial fibrillation: results from ORBIT-AF registry","volume":"170","author":"Pokorney","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.thromres.2021.04.011_bb0075","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/bcp.13046","article-title":"Impact of age on long-term anticoagulation and how gender and monitoring setting affect it: implications for decision making and patient management","volume":"82","author":"Abohelaika","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1472-6963-13-85","article-title":"Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics","volume":"13","author":"Arbring","year":"2013","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.thromres.2021.04.011_bb0085","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.thromres.2015.06.007","article-title":"Determinants of oral anticoagulation control in new warfarin patients: analysis using data from Clinical Practice Research Datalink","volume":"136","author":"Macedo","year":"2015","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2021.04.011_bb0090","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood-2009-02-207928","article-title":"Outcomes and predictors of very stable INR control during chronic anticoagulation therapy","volume":"114","author":"Witt","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2021.04.011_bb0095","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1161\/STROKEAHA.116.013173","article-title":"Female sex, time in therapeutic range, and clinical outcomes in atrial fibrillation patients taking warfarin","volume":"47","author":"Senoo","year":"2016","journal-title":"Stroke."},{"key":"10.1016\/j.thromres.2021.04.011_bb0100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J. Chronic Dis."},{"key":"10.1016\/j.thromres.2021.04.011_bb0105","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.04.011_bb0110","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jclinepi.2010.02.015","article-title":"Charlson and Rx-risk comorbidity indices were predictive of mortality in the Australian health care setting","volume":"64","author":"Lu","year":"2011","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0115","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1055\/s-0038-1651587","article-title":"A method to determine the optimal intensity of oral anticoagulant therapy","volume":"69","author":"Rosendaal","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2021.04.011_bb0120","doi-asserted-by":"crossref","first-page":"54194","DOI":"10.18632\/oncotarget.10944","article-title":"Age is associated with time in therapeutic range for warfarin therapy in patients with atrial fibrillation","volume":"7","author":"Rodrigues Marcatto","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.thromres.2021.04.011_bb0125","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/phar.2089","article-title":"Influence of age on warfarin dose, anticoagulation control, and risk of haemorrhage","volume":"38","author":"Shendre","year":"2018","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.thromres.2021.04.011_bb0130","doi-asserted-by":"crossref","first-page":"m1154","DOI":"10.2174\/1389200220666191021094906","article-title":"Sexual dimorphism in drug metabolism and pharmacokinetics","volume":"20","author":"Valodara","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.thromres.2021.04.011_bb0135","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijcard.2019.02.004","article-title":"Thrombotic and hemorrhagic burden in women: gender-related issues in the response to antithrombotic therapies","volume":"286","author":"Renda","year":"2019","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jmhg.2005.04.010","article-title":"Eating and dieting differences in men and women","volume":"2","author":"Kiefer","year":"2005","journal-title":"J. Men\u2019s Health Gend."},{"key":"10.1016\/j.thromres.2021.04.011_bb0145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jand.2012.08.011","article-title":"Diet quality of Americans differs by age, sex, race\/ethnicity, income, and education level","volume":"113","author":"Hiza","year":"2013","journal-title":"J. Acad. Nutr. Diet."},{"key":"10.1016\/j.thromres.2021.04.011_bb0150","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/j.jada.2006.07.017","article-title":"Sex differences in dieting trends, eating habits, and nutrition beliefs of a group of midwestern college students","volume":"106","author":"Davy","year":"2006","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.thromres.2021.04.011_bb0155","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1177\/1060028018771264","article-title":"Gender differences in efficacy and safety of direct oral anticoagulants in atrial fibrillation: systematic review and network meta-analysis","volume":"52","author":"Raccah","year":"2018","journal-title":"Ann. Pharmacother."},{"issue":"72","key":"10.1016\/j.thromres.2021.04.011_bb0160","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jacc.2018.04.066","article-title":"Sex-based differences in outcomes of oral anticoagulation in patients with atrial fibrillation","volume":"17","author":"Law","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2021.04.011_bb0165","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.015689","article-title":"Sex differences in oral anticoagulation and outcomes of stroke and intracranial bleeding in newly diagnosed atrial fibrillation","volume":"9","author":"Yong","year":"2020","journal-title":"J. Am. Heart Assoc."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821002966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384821002966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:45:13Z","timestamp":1758735913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384821002966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":33,"alternative-id":["S0049384821002966"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2021.04.011","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time in therapeutic range is lower in women than in men and is not explained by differences in age or comorbidity","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2021.04.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}